TRAF3IP2 gene deletion reduces atherosclerosis in female ApoE−/− mice.
TRAF3IP2 gene deletion decreases plaque necrotic core size in both genders.
TRAF3IP2 gene deletion increases features of plaque stability.
TRAF3IP2 gene deletion inhibits aortic proinflammatory and extracellular matrix genes.
TRAF3IP2 could be a potential therapeutic target in atherosclerotic vascular diseases.